Research in Experimental Medicine

, Volume 183, Issue 3, pp 203–213 | Cite as

The effect of peritoneal lavage and aprotinin in the treatment of severe acute pancreatitis

  • G. Balldin
  • A. Borgström
  • S. Genell
  • K. Ohlsson
Original Papers


Fifty-five patients with severe acute pancreatitis were treated with peritoneal lavage at the Dept. of Surgery at Malmö General Hospital. In a randomized study 26 of the 55 patients received in addition 500,000 KIU aprotinin in the lavage fluid every 2 h. There were no significant differences between the aprotinin- and non-aprotinin-treated groups as to mortality and clinical results. The initial concentration ofα1-antitrypsin in plasma was mainly within normal range with increasing values during the treatment. No differences were seen between the two groups. The initial mean level ofα2-macroglobulin in plasma was slightly decreased, but 17 patients showed values below normal range. Theα2-macroglobulin level during the lavage showed a similar course in the two groups.α1-Antitrypsin andα2-macroglobulin in the lavage fluids showed signs of complexation but in plasma these inhibitors did not show any signs of complexation. On admission to the hospital the mean levels of C3 and kininogen in the plasma were slightly below normal. During the lavage treatment no differences were seen between the two groups. Degradation products of C3 and kininogen were seen in both serum and peritoneal fluids. The electrophoretic patterns of C3 and kininogen normalized in serum as well as in lavage fluids during the lavage treatment without any significant differences in the two groups. High levels of immunoreactive trypsin, pancreatic elastase, PSTI, and leukocyte elastase in serum were seen equally in both groups of patients.

Key words

Acute pancreatitis α1-Antitrypsin α2-Macroglobulin Kallikrein-trypsin inactivator Trypsin inhibitors 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Aronsen KF, Ekelund G, Kindmark CO, Laurell CB (1972) Sequential changes of plasma proteins after surgical trauma. Scand J Clin Lab Invest [Suppl 124] 29:127–136Google Scholar
  2. 2.
    Baden H, Jordal K, Lund F, Zachariae F (1969) Prophylactic and curative action of Trasylol in pancreatitis. A double-blind trial. Scand J Gastroenterol 4:291–295PubMedGoogle Scholar
  3. 3.
    Balldin G, Eddeland A, Ohlsson K (1981) Studies on the role of the plasma protease inhibitors on in vitro C3 activation and in acute pancreatitis. Scand J Gastroenterol 16:603–609PubMedGoogle Scholar
  4. 4.
    Balldin G, Gustafsson EL, Ohlsson K (1980) Influence of plasma protease inhibitors and Trasylol on trypsin-induced bradykinin release in vitro and in vivo. Eur Surg Res 12:260–269PubMedGoogle Scholar
  5. 5.
    Balldin G, Ohlsson K (1979) Trasylol prevents trypsin-induced shock in dogs. Hoppe-Seylers Z Physiol Chem 360:651–656PubMedGoogle Scholar
  6. 6.
    Balldin G, Ohlsson K (1979) Demonstration of pancreatic protease-antiprotease complexes in the peritoneal fluid of patients with acute pancreatitis. Surgery 85:451–456PubMedGoogle Scholar
  7. 7.
    Balldin G, Ohlsson K, Olsson A-S (1978) Studies on the influence of Trasylol on the partition of trypsin between the human plasma protease inhibitors in vitro. Hoppe-Seylers Z Physiol Chem 359:691–697PubMedGoogle Scholar
  8. 8.
    Bolooki H, Gliedman ML (1968) Peritoneal dialysis in treatment of acute pancreatitis. Surgery 64:466–471PubMedGoogle Scholar
  9. 9.
    Borgström A, Kukora J, Ohlsson K (1980) Studies on immunoreactive pancreatic elastase 2 in human serum. Hoppe-Seylers Z Physiol Chem 361:633–640PubMedGoogle Scholar
  10. 10.
    Borgström A, Ohlsson K (1978) Immunoreactive trypsin in serum and peritoneal fluid in acute pancreatitis. Hoppe-Seylers Z Physiol Chem 359:677–681PubMedGoogle Scholar
  11. 11.
    Eddeland A, Ohlsson K (1978) A radioimmunoassay for measurement of human pancreatic secretory trypsin inhibitor in different body fluids. Hoppe-Seylers Z Physiol Chem 359:671–675PubMedGoogle Scholar
  12. 12.
    Eddeland A, Ohlsson K (1978) Purification and immunochemical quantitation of human pancreatic secretory trypsin inhibitor. Scand J Clin Lab Invest 38:261–267PubMedGoogle Scholar
  13. 13.
    Ganrot PO (1972) Crossed immunoelectrophoresis. Scand J Clin Lab Invest [Suppl 124] 29:39–41Google Scholar
  14. 14.
    Gjessing J (1967) Peritoneal dialysis in severe acute hemorrhagic pancreatitis. Acta Chir Scand 133:645–647PubMedGoogle Scholar
  15. 15.
    Gliedman ML, Bolooki H, Rosen RG (1970) Acute pancreatitis. Curr Probl SurgGoogle Scholar
  16. 16.
    Goldstein IM, Cala D, Radin A, Kaplan HB, Horn J, Ranson J (1978) Evidence of complement catabolism in acute pancreatitis. Am J Med Sci 275:257–264PubMedGoogle Scholar
  17. 17.
    Lasson Å, Ohlsson K (1983) On the potential role of trypsin and trypsin inhibitors in acute pancreatitis. Plenum, LondonGoogle Scholar
  18. 18.
    Laurell C-B (1972) Electroimmunoassay. Scand J Clin Lab Invest [Suppl 124] 29:21–37Google Scholar
  19. 19.
    Ohlsson K (1971) Elimination of125I-trypsinα-macroglobulin complexes from blood by reticuloendothelial cells in dog. Acta Physiol Scand 81:269–272PubMedGoogle Scholar
  20. 20.
    Ohlsson K, Olsson I (1974) The neutral proteases of human granulocytes. Isolation and partial characterization of granulocyte elastase. Eur J Biochem 42:519–527PubMedGoogle Scholar
  21. 21.
    Ohlsson K, Olsson A-S (1978) Immunoreactive granulocyte elastase in human serum. Hoppe-Seylers Z Physiol Chem 359:1531–1539PubMedGoogle Scholar
  22. 22.
    Ranson JHC, Rifkind K, Turner JW (1976) Prognostic signs and non-operative peritoneal lavage in acute pancreatitis. Surg Gynecol Obstet 143:209–219PubMedGoogle Scholar
  23. 23.
    Ranson JHC, Spencer FC (1978) The role of peritoneal lavage in severe acute pancreatitis. Am Surg 187:565–575Google Scholar
  24. 24.
    Rosato EF, Mullis WF, Rosato FE (1973) Peritoneal lavage therapy in hemorrhagic pancreatitis. Surgery 74:106–115PubMedGoogle Scholar
  25. 25.
    Trapnell JE, Rigby CC, Talbot CH, Duncan EHL (1974) A controlled trial of Trasylol in the treatment of acute pancreatitis. Br J Surg 61:177–182PubMedGoogle Scholar
  26. 26.
    Trapnell JE, Talbot CH, Capper WM (1967) Trasylol in acute pancreatitis. Am J Digest Dis 12:409–412PubMedGoogle Scholar
  27. 27.
    Welbourn RB, Armitage P, Gilmore OJA, McKay C, Trapnell JE, Williamson RCN (1977) Death from acute pancreatitis. MRC multicentre trial of glucagon and aprotinin. Lancet 2:632–635PubMedGoogle Scholar

Copyright information

© Springer-Verlag 1983

Authors and Affiliations

  • G. Balldin
    • 1
  • A. Borgström
    • 1
  • S. Genell
    • 1
  • K. Ohlsson
    • 1
  1. 1.Departments of Surgery, Clinical Chemistry, and Experimental ResearchMalmö General Hospital, University of LundMalmöSweden

Personalised recommendations